Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 04, 2021

Benefits of Antiplatelet Therapy During COVID-19 Hospitalisation Without Increased Bleeding Risk

Heart (British Cardiac Society)


Additional Info

Heart (British Cardiac Society)
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry
Heart 2021 Oct 05;[EPub Ahead of Print], F Santoro, IJ Nuñez-Gil, E Vitale, MC Viana-Llamas, B Reche-Martinez, R Romero-Pareja, G Feltez Guzman, I Fernandez Rozas, A Uribarri, VM Becerra-Muñoz, E Alfonso-Rodriguez, M Garcia-Aguado, J Huang, ME Ortega-Armas, JF Garcia Prieto, EM Corral Rubio, F Ugo, M Bianco, A Mulet, S Raposeiras-Roubin, JL Jativa Mendez, C Espejo Paeres, AR Albarrán, F Marín, F Guerra, I Akin, B Cortese, H Ramakrishna, C Macaya, A Fernandez-Ortiz, ND Brunetti

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading